Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

304 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase II Trial of Nivolumab in Metastatic Rare Cancer with dMMR or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial).
Okuma HS, Watanabe K, Tsuchihashi K, Machida R, Sadachi R, Hirakawa A, Ariyama H, Kanai M, Kamikura M, Anjo K, Hiramitsu A, Sekine S, Okita N, Mano H, Nishikawa H, Nakamura K, Yonemori K. Okuma HS, et al. Among authors: tsuchihashi k. Clin Cancer Res. 2023 Dec 15;29(24):5079-5086. doi: 10.1158/1078-0432.CCR-23-1807. Clin Cancer Res. 2023. PMID: 37819940 Free PMC article. Clinical Trial.
Programmed death-ligand 1 expression is associated with fibrosarcomatous transformation of dermatofibrosarcoma protuberans.
Tsuchihashi K, Kusaba H, Yamada Y, Okumura Y, Shimokawa H, Komoda M, Uchino K, Yoshihiro T, Tsuruta N, Hanamura F, Inadomi K, Ito M, Sagara K, Nakano M, Nio K, Arita S, Ariyama H, Kohashi K, Tominaga R, Oda Y, Akashi K, Baba E. Tsuchihashi K, et al. Mol Clin Oncol. 2017 May;6(5):665-668. doi: 10.3892/mco.2017.1197. Epub 2017 Mar 17. Mol Clin Oncol. 2017. PMID: 28515919 Free PMC article.
Suggestion of added value by bevacizumab to chemotherapy in patients with unresectable or recurrent small bowel cancer.
Takayoshi K, Kusaba H, Uenomachi M, Mitsugi K, Makiyama C, Makiyama A, Uchino K, Shirakawa T, Shibata Y, Shinohara Y, Inadomi K, Tsuchihashi K, Arita S, Ariyama H, Esaki T, Akashi K, Baba E. Takayoshi K, et al. Among authors: tsuchihashi k. Cancer Chemother Pharmacol. 2017 Aug;80(2):333-342. doi: 10.1007/s00280-017-3371-0. Epub 2017 Jun 26. Cancer Chemother Pharmacol. 2017. PMID: 28653251 Free article.
Lingual alveolar soft part sarcoma responsive to pazopanib: A case report.
Yoshihiro T, Tsuchihashi K, Nio K, Arita S, Nakano T, Yasumatsu R, Jiroumaru R, Ariyama H, Kusaba H, Oda Y, Akashi K, Baba E. Yoshihiro T, et al. Among authors: tsuchihashi k. Medicine (Baltimore). 2017 Nov;96(44):e8470. doi: 10.1097/MD.0000000000008470. Medicine (Baltimore). 2017. PMID: 29095301 Free PMC article.
Metastatic esophageal cancer presenting as shock by injury of vagus nerve mimicking baroreceptor reflex: A case report.
Tsuchihashi K, Yoshihiro T, Aikawa T, Nio K, Takayoshi K, Yokoyama T, Fukata M, Arita S, Ariyama H, Shimizu Y, Yoshida Y, Torisu T, Esaki M, Odashiro K, Kusaba H, Akashi K, Baba E. Tsuchihashi K, et al. Medicine (Baltimore). 2017 Dec;96(49):e8987. doi: 10.1097/MD.0000000000008987. Medicine (Baltimore). 2017. PMID: 29245271 Free PMC article.
Successful chemotherapeutic treatment for metastatic littoral cell angioma: A case report.
Takayoshi K, Doi G, Tsuruta N, Yoshihiro T, Nio K, Tsuchihashi K, Ariyama H, Odawara J, Shimoda S, Kohashi K, Oda Y, Itoh S, Harimoto N, Maehara Y, Kusaba H, Akashi K, Baba E. Takayoshi K, et al. Among authors: tsuchihashi k. Medicine (Baltimore). 2018 Apr;97(15):e0378. doi: 10.1097/MD.0000000000010378. Medicine (Baltimore). 2018. PMID: 29642193 Free PMC article.
The risk factors for oxaliplatin-induced peripheral sensory neuropathy and thrombocytopenia in advanced gastric cancer.
Yamaguchi K, Kusaba H, Makiyama A, Mitsugi K, Uchino K, Tamura S, Shibata Y, Esaki T, Ito M, Takayoshi K, Tsuchihashi K, Arita S, Ariyama H, Akashi K, Baba E. Yamaguchi K, et al. Among authors: tsuchihashi k. Cancer Chemother Pharmacol. 2018 Oct;82(4):625-633. doi: 10.1007/s00280-018-3652-2. Epub 2018 Jul 24. Cancer Chemother Pharmacol. 2018. PMID: 30043209
Activation of central/effector memory T cells and T-helper 1 polarization in malignant melanoma patients treated with anti-programmed death-1 antibody.
Yamaguchi K, Mishima K, Ohmura H, Hanamura F, Ito M, Nakano M, Tsuchihashi K, Ota SI, Wada N, Uchi H, Ariyama H, Kusaba H, Niiro H, Akashi K, Baba E. Yamaguchi K, et al. Among authors: tsuchihashi k. Cancer Sci. 2018 Oct;109(10):3032-3042. doi: 10.1111/cas.13758. Epub 2018 Aug 31. Cancer Sci. 2018. PMID: 30066977 Free PMC article. Clinical Trial.
304 results